Cargando…
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
A standardized nomenclature for reporting oncology biomarker variants is key to avoid misinterpretation of results and unambiguous registration in clinical databases. External quality assessment (EQA) schemes have revealed a need for more consistent nomenclature use in clinical genetics. We evaluate...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973115/ https://www.ncbi.nlm.nih.gov/pubmed/31553104 http://dx.doi.org/10.1002/humu.23926 |